• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Almost All Blood Donors Had SARS-CoV-2 Antibodies by Third Quarter of 2022

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, June 8, 2023 -- Almost all blood donors had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies from previous infection or vaccination by the third quarter of 2022, with the prevalence of hybrid immunity lowest for adults aged ≥65 years, according to research published in the June 2 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Jefferson M. Jones, M.D., from the CDC in Atlanta, and colleagues estimated the incidence of infection and prevalence of infection- or vaccination-induced SARS-CoV-2 antibodies using data from a nationwide, longitudinal cohort of blood donors.

The researchers found that an estimated 68.4 percent of persons aged ≥16 years had infection- or vaccination-induced SARS-CoV-2 antibodies during the second quarter of 2021, including 47.5, 12.0, and 8.9 percent from vaccination alone, infection alone, and both, respectively. Overall, 96.4 percent had SARS-CoV-2 antibodies by the third quarter of 2022, including 22.6, 26.1, and 47.7 percent from infection alone, vaccination alone, and hybrid immunity, respectively. Adults aged ≥65 years had the lowest prevalence of hybrid immunity (36.9 percent), and they had the highest risk for severe disease if infected; the prevalence of hybrid immunity was highest among those aged 16 to 29 years (59.6 percent).

"Compared with vaccine effectiveness against any infection and against severe disease or hospitalization, the effectiveness of hybrid immunity against these outcomes has been shown to be higher and wane more slowly," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted June 2023

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.